DCOY
HEALTHCAREDecoy Therapeutics Inc Com Par 0.0001 New
$6.01+0.17 (+2.91%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving DCOY Today?
No stock-specific AI insight has been generated for DCOY yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.15$239.40
$6.01
Fundamentals
Market Cap$3M
P/E Ratio—
EPS$-129.10
Dividend Yield—
Dividend / Share—
ROE-3.4%
Profit Margin—
Debt / Equity—
Trading
Volume11K
Avg Volume (10D)—
Shares Outstanding532K
DCOY News
10 articles- Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in BostonYahoo Finance·Apr 27, 2026
- Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral PipelineYahoo Finance·Apr 9, 2026
- Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026Yahoo Finance·Apr 6, 2026
- Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo Finance·Apr 2, 2026
- Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation PlatformYahoo Finance·Mar 11, 2026
- Decoy Therapeutics Announces 1-for-12 Reverse Stock SplitYahoo Finance·Mar 5, 2026
- Decoy Therapeutics Joins Webull Corporate Connect Service PlatformYahoo Finance·Feb 11, 2026
- Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull FinancialYahoo Finance·Feb 5, 2026
- Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment AgreementYahoo Finance·Feb 4, 2026
- Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing PlatformYahoo Finance·Jan 13, 2026
All 10 articles loaded
Price Data
Open$6.00
Previous Close$5.84
Day High$6.24
Day Low$5.81
52 Week High$239.40
52 Week Low$5.15
52-Week Range
$5.15$239.40
$6.01
Fundamentals
Market Cap$3M
P/E Ratio—
EPS$-129.10
Dividend Yield—
Dividend / Share—
ROE-3.4%
Profit Margin—
Debt / Equity—
Trading
Volume11K
Avg Volume (10D)—
Shares Outstanding532K
About Decoy Therapeutics Inc Com Par 0.0001 New
Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. The company is headquartered in Cambridge, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—